Search filters

Filters
Clear All

Phase

  • 1
  • 1
  • 1
  • 3
  • 6
  • 1
  • 6

Found 6 Liver Cancer trials

A listing of Liver Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Sort by:
18 years - 85 years
All genders
Phase 4
Interventional
This study investigates methods for screening liver cancer in patients with cirrhosis or chronic hepatitis B. The purpose of this study is to compare two screening methods: one using ultrasound and a protein marker called AFP, and another using a biomarker called GALAD. Participants will be divided into two study …
18 years - 99 years
All genders
Interventional
This study investigates the use of a medical device containing yttrium-90 for treating liver cancer, specifically Hepatocellular Carcinoma (HCC). The purpose of this study is to evaluate the safety and effectiveness of Eye90 microspheres, which deliver localized radiation therapy directly to liver tumors. This approach is used for patients whose …
18 years - 130 years
All genders
Observational
The purpose of this study is to investigate the effectiveness of an investigational medication in patients with HER2-positive solid tumors that are locally advanced, unresectable, or metastatic. In this study, HER2-positive is identified as IHC 3+. The study focuses on patients who have previously received systemic treatment for their condition …
99 years or below
All genders
To acquire baseline and serial HCC cancer core biopsy samples in order to characterize the epigenetic, proteomic, metabolomic and immunologic profile of hepatocellular carcinoma cells surviving TACE. See section 2 of full protocol. See section 3.2 full protocol. See section 3.3 full protocol.
20 years - 99 years
All genders
Phase 1/2
Interventional
This study investigates a treatment for liver metastases from neuroendocrine tumors. It aims to find the best dose and safety of a hypoxia-activating agent combined with embolization, a procedure that blocks blood flow to cancer cells. The agent, administered directly into the liver's arteries, is evaluated using MRI scans based …
18 years or above
All genders
Phase 2
Interventional
This study investigates the safety and effects of an investigational medication in adults with carcinoid syndrome. The purpose of this study is to evaluate how the investigational medication works in the body and its safety for people with this syndrome.Participants will first be randomly assigned to receive either the investigational …